Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1668

1.

Effect of sweet almond syrup versus methylphenidate in children with ADHD: A randomized triple-blind clinical trial.

Motaharifard MS, Effatpanah M, Karimi M, Akhondzadeh S, Rahimi H, Yasrebi SA, Nejatbakhsh F.

Complement Ther Clin Pract. 2019 Aug;36:170-175. doi: 10.1016/j.ctcp.2019.07.008. Epub 2019 Jul 19.

PMID:
31383435
2.

Comprehensive Real-World Assessment of Marketed Medications to Guide Parkinson's Drug Discovery.

Cepeda MS, Kern DM, Seabrook GR, Lovestone S.

Clin Drug Investig. 2019 Nov;39(11):1067-1075. doi: 10.1007/s40261-019-00830-4.

3.

Modeling the effects of methylphenidate on interference and evidence accumulation processes using the conflict linear ballistic accumulator.

Weigard A, Heathcote A, Sripada C.

Psychopharmacology (Berl). 2019 Aug;236(8):2501-2512. doi: 10.1007/s00213-019-05316-x. Epub 2019 Jul 13.

PMID:
31302719
4.

The impact of human CES1 genetic variation on enzyme activity assessed by ritalinic acid/methylphenidate ratios.

Stage C, Dalhoff K, Rasmussen HB, Schow Guski L, Thomsen R, Bjerre D, Ferrero-Miliani L, Busk Madsen M, Jürgens G.

Basic Clin Pharmacol Toxicol. 2019 Jul;125(1):54-61. doi: 10.1111/bcpt.13212. Epub 2019 Apr 24.

PMID:
30801959
5.

Catecholaminergic modulation of trust decisions.

Rățală CE, Fallon SJ, van der Schaaf ME, Ter Huurne N, Cools R, Sanfey AG.

Psychopharmacology (Berl). 2019 Jun;236(6):1807-1816. doi: 10.1007/s00213-019-5165-z. Epub 2019 Jan 31.

6.

A randomized comparison of long acting methylphenidate and cognitive behavioral therapy in the treatment of binge eating disorder.

Quilty LC, Allen TA, Davis C, Knyahnytska Y, Kaplan AS.

Psychiatry Res. 2019 Mar;273:467-474. doi: 10.1016/j.psychres.2019.01.066. Epub 2019 Jan 17.

PMID:
30684794
7.

Hyperactivity/restlessness is associated with increased functional connectivity in adults with ADHD: a dimensional analysis of resting state fMRI.

Sörös P, Hoxhaj E, Borel P, Sadohara C, Feige B, Matthies S, Müller HHO, Bachmann K, Schulze M, Philipsen A.

BMC Psychiatry. 2019 Jan 25;19(1):43. doi: 10.1186/s12888-019-2031-9.

8.

[Efficacy of fluvoxamine combined with extended-release methylphenidate on treatment-refractory obsessive-compulsive disorder].

Zheng H, Jia F, Guo G, Quan D, Li G, Huang H.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2018 Nov 28;43(11):1230-1235. doi: 10.11817/j.issn.1672-7347.2018.11.010. Chinese.

9.

Combined fluvoxamine and extended-release methylphenidate improved treatment response compared to fluvoxamine alone in patients with treatment-refractory obsessive-compulsive disorder: A randomized double-blind, placebo-controlled study.

Zheng H, Jia F, Han H, Wang S, Guo G, Quan D, Li G, Huang H.

Eur Neuropsychopharmacol. 2019 Mar;29(3):397-404. doi: 10.1016/j.euroneuro.2018.12.010. Epub 2018 Dec 27.

PMID:
30595354
10.

Does L-Methylfolate Supplement Methylphenidate Pharmacotherapy in Attention-Deficit/Hyperactivity Disorder?: Evidence of Lack of Benefit From a Double-Blind, Placebo-Controlled, Randomized Clinical Trial.

Surman C, Ceranoglu A, Vaudreuil C, Albright B, Uchida M, Yule A, Spencer A, Boland H, Grossman R, Rhodewalt L, Fitzgerald M, Biederman J.

J Clin Psychopharmacol. 2019 Jan/Feb;39(1):28-38. doi: 10.1097/JCP.0000000000000990.

11.

Effects of Methylphenidate During Fear Learning in Antisocial Adolescents: A Randomized Controlled fMRI Trial.

van Lith K, Veltman DJ, Cohn MD, Pape LE, van den Akker-Nijdam ME, van Loon AWG, Bet P, van Wingen GA, van den Brink W, Doreleijers T, Popma A.

J Am Acad Child Adolesc Psychiatry. 2018 Dec;57(12):934-943. doi: 10.1016/j.jaac.2018.06.026. Epub 2018 Sep 26.

PMID:
30522739
12.

Effect of vitamin D treatment in children with attention-deficit hyperactivity disorder.

Dehbokri N, Noorazar G, Ghaffari A, Mehdizadeh G, Sarbakhsh P, Ghaffary S.

World J Pediatr. 2019 Feb;15(1):78-84. doi: 10.1007/s12519-018-0209-8. Epub 2018 Nov 19.

PMID:
30456564
13.

Early monitoring of fatty acid profile in children with attention deficit and/or hyperactivity disorder under treatment with omega-3 polyunsaturated fatty acids.

Checa-Ros A, Haro-García A, Seiquer I, Molina-Carballo A, Uberos-Fernández J, Muñoz-Hoyos A.

Minerva Pediatr. 2019 Aug;71(4):313-325. doi: 10.23736/S0026-4946.18.04975-7. Epub 2018 Nov 7.

PMID:
30419741
14.

Effects of lisdexamfetamine on plasma steroid concentrations compared with d-amphetamine in healthy subjects: A randomized, double-blind, placebo-controlled study.

Strajhar P, Vizeli P, Patt M, Dolder PC, Kratschmar DV, Liechti ME, Odermatt A.

J Steroid Biochem Mol Biol. 2019 Feb;186:212-225. doi: 10.1016/j.jsbmb.2018.10.016. Epub 2018 Oct 28.

PMID:
30381248
15.

Preventive effect of cyproheptadine on sleep and appetite disorders induced by methylphenidate: an exploratory randomised, double-blinded, placebo-controlled clinical trial.

Kadkhoda Mezerji F, Moharreri F, Mohammadpour AH, Elyasi S.

Int J Psychiatry Clin Pract. 2019 Mar;23(1):72-79. doi: 10.1080/13651501.2018.1509095. Epub 2018 Sep 27.

PMID:
30261781
16.

Dissecting genetic cross-talk between ADHD and other neurodevelopmental disorders: Evidence from behavioural, pharmacological and brain imaging investigations.

Sengupta SM, Fotopoulos N, Devenyi GA, Fortier MÈ, Ter-Stepanian M, Sagliker S, Karama S, Mallar Chakravarty M, Labbe A, Grizenko N, Joober R.

Psychiatry Res. 2018 Nov;269:652-657. doi: 10.1016/j.psychres.2018.08.080. Epub 2018 Aug 28.

PMID:
30216917
17.

The efficacy of Ritalin in ADHD children under neurofeedback training.

Pakdaman F, Irani F, Tajikzadeh F, Jabalkandi SA.

Neurol Sci. 2018 Dec;39(12):2071-2078. doi: 10.1007/s10072-018-3539-3. Epub 2018 Sep 5.

PMID:
30187306
18.

Effects of methylphenidate on cognition and behaviour in children with neurofibromatosis type 1: a study protocol for a randomised placebo-controlled crossover trial.

Pride NA, Barton B, Hutchins P, Coghill DR, Korgaonkar MS, Hearps SJC, Rouel M, Malarbi S, North KN, Payne JM.

BMJ Open. 2018 Aug 30;8(8):e021800. doi: 10.1136/bmjopen-2018-021800.

19.

Aripiprazole/Methylphenidate Combination in Children and Adolescents with Disruptive Mood Dysregulation Disorder and Attention-Deficit/Hyperactivity Disorder: An Open-Label Study.

Pan PY, Fu AT, Yeh CB.

J Child Adolesc Psychopharmacol. 2018 Dec;28(10):682-689. doi: 10.1089/cap.2018.0068. Epub 2018 Aug 27.

PMID:
30148656
20.

Cognitive Working Memory Training (CWMT) in adolescents suffering from Attention-Deficit/Hyperactivity Disorder (ADHD): A controlled trial taking into account concomitant medication effects.

Ackermann S, Halfon O, Fornari E, Urben S, Bader M.

Psychiatry Res. 2018 Nov;269:79-85. doi: 10.1016/j.psychres.2018.07.036. Epub 2018 Jul 27.

Supplemental Content

Loading ...
Support Center